Abraxis BioScience

Abraxis BioScience, Inc. is a biotechnology company dedicated to the discovery, development, and delivery of next-generation therapeutic treatments and core technologies for the treatment of cancer and other critical diseases. The company primarily offers Abraxane, a nanoparticle chemotherapy compound based on its proprietary tumor-targeting nab technology platform, used for the treatment of metastatic breast cancer.